DXCM Financial Facts
Total revenue: 148.6MInterest expense: -200K
See Full Income Statement
Short-term marketable securities, available-for-sale: 29.6M
Total current liabilities: 86.1M
See Full Balance Sheet
DexCom, Inc. (DXCM) Earnings
|
Expand Research on DXCM
| Next EPS Date | 4/25/24 | EPS Growth Rate | +58.8% |
|---|---|---|---|
| Average EPS % Beat Rate | +31.1% | Revenue Growth Rate | +22.7% |
| Average % Move 1-Wk after EPS | -0.4% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
4/25/24  |
Q124 | N/A | $0.27 | N/A | N/A | $909.93M | = | N/A | N/A | ||
| 4/28/22 |  |
Q122 | $0.32 | $0.52 | -$0.20 | $628.8M | $624.47M | = |  | | Details |
| 2/10/22 | |
Q421 | $0.68 | $0.85 | -$0.17 | $698.2M | $696.47M | = | | | Details |
| 8/2/16 |
|
Q216 | -$0.24 | -$0.12 | -$0.12 | $137.3M | $132.59M | N/A | | | Details |
| 5/1/14 |
|
Q114 | -$0.17 | -$0.08 | -$0.09 | $46.7M | $44.15M | N/A | | | Details |
| 11/1/16 |
|
Q316 | -$0.22 | -$0.13 | -$0.09 | $148.6M | $146.26M | N/A | | | Details |
| 4/29/15 |
|
Q115 | -$0.17 | -$0.11 | -$0.06 | $72.8M | $71.32M | N/A | | | Details |
| 11/4/15 |
|
Q315 | -$0.07 | -$0.01 | -$0.06 | $105.2M | $99.88M | N/A | | | Details |
